Is the TB SPOT (Tuberculosis Spot) test a Nucleic Acid Amplification Test (NAAT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, the TB SPOT test is not a Nucleic Acid Amplification Test (NAAT). The TB SPOT test is an interferon-gamma release assay (IGRA) that detects cell-mediated immune responses to Mycobacterium tuberculosis antigens, as described in the ecco guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease 1. It works by measuring the number of T cells that release interferon-gamma when stimulated by antigens specific to M. tuberculosis. Blood samples are collected from patients, and their T cells are exposed to TB-specific antigens. If the person has been infected with TB, their T cells will recognize these antigens and release interferon-gamma, which is then detected and quantified.

Key differences between TB SPOT and NAAT

  • NAATs directly detect genetic material (DNA or RNA) of the TB bacteria through amplification techniques like PCR, as discussed in the official american thoracic society/infectious diseases society of america/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children 1.
  • The TB SPOT test is used primarily for diagnosing latent TB infection rather than active disease, and it offers advantages over the traditional tuberculin skin test by having higher specificity and not being affected by prior BCG vaccination.

Clinical implications

  • The choice between TB SPOT and NAAT depends on the clinical context and the purpose of the test, with NAAT being recommended for rapid diagnosis of active TB, especially in patients with suspected pulmonary TB 1.
  • The TB SPOT test is a useful tool for diagnosing latent TB infection, particularly in individuals who have been exposed to TB or who are at high risk of developing the disease.

From the Research

TB SPOT Test Classification

  • The TB SPOT test is not a Nucleic Acid Amplification Test (NAAT) 2

Key Characteristics of NAAT Tests

  • NAAT tests have high specificity, making them useful for ruling in TB 2
  • NAAT tests have poor sensitivity, making them less useful for ruling out TB, especially in smear-negative disease 2

Comparison of Diagnostic Tests

  • NAAT tests are more accurate than other tests, such as adenosine deaminase (ADA) tests, for diagnosing TB meningitis and pleural TB 2
  • Fully automated liquid culture methods are superior to culture on solid media for detecting TB 3

Turnaround Time for Laboratory Diagnosis

  • The use of NAAT tests can reduce the turnaround time for laboratory diagnosis of pulmonary TB by approximately 2 weeks 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.